![]() |
市場調查報告書
商品編碼
1980223
尿液流量計市場規模、佔有率、成長及全球產業分析:按類型、應用和地區分類的洞察,2026-2034 年預測Urinary Flow Meters Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
2025年全球尿流量計市場規模為2,320萬美元,預計2026年將成長至2,510萬美元。到2034年,該市場預計將達到5,010萬美元,2026年至2034年的年複合成長率為9%。2025年,北美在全球市場中佔據領先地位,佔總營收的39.5%。
尿流率儀(也稱為尿流計)是一種用於測量尿液流速和尿量的診斷設備。這些系統有助於診斷泌尿系統疾病,例如良性前列腺增生(BPH)、尿失禁、閉尿症、膀胱癌和攝護腺癌。由於其操作簡便、性能優異、測量精準,且能與數位系統整合,因此在醫院和專科診所中的應用顯著增加。
市場動態
市場促進因素
泌尿系統疾病盛行率增加
全球泌尿系統疾病負擔日益加重是推動市場成長的主要因素。應力性尿失禁的盛行率很高,這顯著提高了尿流率檢測的需求。
老年人口增加
隨著全球老年人口的成長,泌尿系統功能障礙的風險也增加。與老齡化相關的膀胱問題和良性前列腺增生顯著推高了對診斷設備的需求。歐洲超過五分之一的人口年齡在65歲以上,受這些人口結構變化的影響,該地區正經歷強勁的成長。
技術進步和新產品的發布
製造商正陸續推出可與電子健康記錄(EMR)系統整合的先進PC型尿流率儀,這些尿流率儀不僅提高了測量精度,還支援數位化診斷。這些創新加速其在技術先進的醫療機構中的應用。
新冠疫情的影響
新冠肺炎疫情導致患者就診量下降,醫院資源也因應對疫情而重新分配,對市場收入造成了負面影響。泌尿系統領域,病床運轉率和門診病人就診量均下降。然而,隨著2021年和2022年手術和診斷就診的恢復,市場逐漸恢復到疫情前的成長水準,預計2025年後將持續穩定成長。
市場趨勢
從非PC型設備遷移到PC型設備
市場的一個主要趨勢是轉向基於PC的尿流量計。這些系統具有以下優勢:
隨著醫療保健系統數位化,預計在整個預測期內,對基於個人電腦的設備的需求將保持強勁。
市場限制因素
儘管預計市場將保持強勁成長,但以下因素可能會阻礙市場擴張:
這些因素導致價格敏感地區的採用率較低。
依類型
從市場區隔來看,尿流量計分為 PC 為基礎的類別和非 PC 為基礎的類別。
最終用戶
市場分為醫院、專科診所和其他機構。
北美洲
預計到2025年,北美市場規模將達到920萬美元,以39.5%的市場佔有率持續保持領先地位。該成長主要得益於基於個人電腦設備的普及率高、醫療保健基礎設施完善以及前列腺癌和膀胱癌發病率的上升。該地區持續推出新產品,並致力於推動數位化診斷。
歐洲
歐洲佔據了相當大的市場佔有率,預計到2034年將保持穩定成長。人口老化加劇和膀胱癌高發生率是推動該地區市場擴張的主要因素。現有的大型企業和完善的醫療保健體系進一步鞏固了市場地位。
亞太地區
預計亞太地區在預測期內將紀錄最高的年複合成長率。人口快速老化、人們對泌尿器官系統健康的日益關注以及日本、中國和印度等國不斷擴大的醫療保健投資,推動該地區的需求成長。
世界其他地區
由於醫療基礎設施的改善和泌尿系統疾病診斷率的提高,拉丁美洲、中東和非洲的市場成長。
The global urinary flow meters market was valued at USD 23.2 million in 2025 and is projected to grow to USD 25.1 million in 2026. The market is expected to reach USD 50.1 million by 2034, registering a CAGR of 9% during 2026-2034. North America dominated the global market in 2025, accounting for 39.5% of total revenue.
Urinary flow meters, also known as uroflowmeters, are diagnostic devices used to measure the rate and volume of urine flow. These systems assist in diagnosing urinary tract disorders such as benign prostatic hyperplasia (BPH), urinary incontinence, urine retention, bladder cancer, and prostate cancer. Their ease of use, improved handling, accurate measurement capabilities, and integration with digital systems have significantly increased adoption across hospitals and specialty clinics.
Market Dynamics
Market Drivers
Rising Prevalence of Urological Disorders
The increasing global burden of urinary tract disorders is a major factor driving market growth. Conditions such as BPH, stress urinary incontinence (SUI), bladder obstruction, and prostate cancer are becoming more common, particularly among aging populations. For instance, studies indicate high prevalence of SUI among women in countries such as China, significantly boosting demand for uroflowmetry testing.
Growing Geriatric Population
The global elderly population continues to rise, increasing susceptibility to urinary dysfunction. Age-related bladder issues and prostate enlargement significantly contribute to demand for diagnostic devices. Europe, where more than one-fifth of the population is aged 65 and above, represents a strong growth region due to this demographic shift.
Technological Advancements and Product Launches
Manufacturers are increasingly launching advanced PC-based urinary flow meters that integrate with Electronic Medical Records (EMRs), offer enhanced accuracy, and support digital diagnostics. These innovations are strengthening adoption across technologically advanced healthcare settings.
COVID-19 Impact
The COVID-19 pandemic negatively affected market revenues due to reduced patient visits and reallocation of hospital resources toward pandemic care. Urology departments experienced reduced bed occupancy and outpatient visits. However, with the resumption of surgical procedures and diagnostic visits in 2021 and 2022, the market gradually returned to pre-pandemic growth levels, supporting steady expansion from 2025 onward.
Market Trends
Transition from Non-PC Based to PC-Based Devices
A key market trend is the increasing shift toward PC-based urinary flow meters. These systems provide:
As healthcare systems continue digitization, demand for PC-based devices is expected to remain strong throughout the forecast period.
Market Restraints
Despite strong growth prospects, certain factors may hinder expansion:
These factors reduce adoption rates in price-sensitive regions.
By Type
The market is segmented into PC-Based and Non-PC Based urinary flow meters.
By End-User
The market is categorized into hospitals, specialty clinics, and others.
North America
North America generated USD 9.2 million in 2025, maintaining its leadership with a 39.5% market share. Growth is driven by high adoption of PC-based devices, strong healthcare infrastructure, and rising prevalence of prostate and bladder cancers. The region continues to see new product launches and digital diagnostic initiatives.
Europe
Europe held a substantial market share and is projected to grow steadily through 2034. Rising geriatric population and high prevalence of bladder cancer support regional expansion. Established players and well-developed healthcare systems further strengthen the market.
Asia Pacific
Asia Pacific is expected to register the highest CAGR during the forecast period. Rapid aging populations, increasing awareness of urinary health, and growing healthcare investments in countries such as Japan, China, and India are driving regional demand.
Rest of the World
Markets in Latin America, the Middle East, and Africa are growing due to improving healthcare infrastructure and rising diagnosis rates of urological conditions.
Competitive Landscape
Key players operating in the global urinary flow meters market include:
Companies are focusing on mergers, acquisitions, regulatory approvals, and product innovations to strengthen their global footprint.
Conclusion
The global urinary flow meters market demonstrates strong growth potential, increasing from USD 23.2 million in 2025 to USD 25.1 million in 2026, and projected to reach USD 50.1 million by 2034, at a 9% CAGR. Rising prevalence of urological disorders, expanding geriatric population, technological advancements, and growing digital integration in healthcare are key growth drivers. While high costs and limited awareness in developing regions may pose challenges, increasing innovation and expanding diagnostic infrastructure are expected to sustain long-term market expansion worldwide.
Segmentation By Type
By End-user
By Geography